Good Chance AstraZeneca (AZN) Releases MYSTIC Top-Line Results Tomorrow - BMO
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Price: $92.77 --0%
Rating Summary:
19 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Rating Summary:
19 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Join SI Premium – FREE
BMO analyst Alex Arfaei thinks there is a good chance AstraZeneca (NYSE: AZN) will release the MYSTIC top-line results tomorrow.
"We continue to believe that there is a reasonable probability that MYSTIC shows positive PFS (combo vs. chemo)," he commented. "However, the uncertainty associated with IO trials has increased, and MYSTIC has plenty of it. We doubt that the PD-1+CTLA4 combos will show meaningfully differentiated clinical profile, and expected a fragmented market."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Imfinzi plus tarlatamab shows survival gains in lung cancer trial
- AstraZeneca COPD drug tozorakimab cuts exacerbations in Phase III trials
- Explosions heard on Iran's Kharg island - MEHR
Create E-mail Alert Related Categories
Analyst Comments, FDA, Hot Comments, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
